Figure 4.
Genetic risk score. Diagnostic accuracy of the Genetic risk score (GRS) for NAFLD-HCC in the 655 individuals included in the study. (a) comparison of the diagnostic accuracy in the study cohorts; p < 0.05 for diagnostic accuracy in the overall vs. single cohorts. (b) Diagnostic accuracy of GRS vs. PNPLA3 I148M variant alone and a combination of PNPLA3 I148M and TM6SF2 E167K variants in determining NAFLD HCC risk; p < 2*10−8 for alternative genetic scores vs. the overall GRS. (c) Additive value of adding GRS to a diagnostic model based on clinical risk factors, in determining NAFLD-HCC risk in the 251 individuals of the EPIDEMIC study; p = 0.17. Comparison of diagnostic accuracy was performed by two-sided Venkatraman test.